Replies to post #248821 on Biotech Values

[vinmantoo]

FTC allows Amgen to move forward with $27.8 billion Horizon Therapeutics deal

That bodes well for SGEN shareholders and their buyout of SGEN. The stock price jumped $3 so far this morning to $209/share, which is still $20 below the agreed buyout price.